Form 4: Accolade Inc. Executive Richard Eskew Reports Stock Transactions
SEC Form 4 Filing
Richard Eskew, EVP General Counsel of Accolade, Inc., reports the acquisition and disposal of common stock and restricted stock units.
Summary
- On April 1, 2024, Richard Eskew, EVP General Counsel of Accolade, Inc., converted 389 and 1,250 restricted stock units (RSUs) into common stock.
- On April 2, 2024, Eskew sold 587 shares of common stock at a price of $9.582 per share.
- Following these transactions, Eskew directly owns 39,001 shares of common stock and 7,942 restricted stock units.
- The sale of shares was to cover tax withholding obligations related to the vesting and settlement of RSUs.
Sentiment
Score: 5
Explanation: This is a neutral report on stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency to investors regarding insider activity.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive stock ownership.
- The sale of shares to cover tax obligations has a minimal impact on the overall market.
Key Dates
| Date | Description |
|---|---|
| June 1, 2021 | June 2021 Vesting Commencement Date for some Restricted Stock Units |
| June 1, 2022 | June 2022 Vesting Commencement Date for some Restricted Stock Units |
| April 1, 2024 | Conversion of Restricted Stock Units to Common Stock |
| April 2, 2024 | Sale of Common Stock |
| April 3, 2024 | Date of Form 4 Filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.